Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane and Lyophilization Amniotic Membrane), Application (Surgical Wounds, Ophthalmology and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Research Centers & Laboratory) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_184559

Pages: 122

Formats:

Feb 2018 | 1714 Views

Charts: 20

Tables: 47

Author(s): Suraj Sajeev & Garima Chandra

Purchase Option


Amniotic Membrane Market Overview:

Amniotic membrane is a sack that surrounds and protects the embryo, enclosing the amniotic cavity. It is utilized as a skin substitute as well as a surgical biomaterial in a variety of settings such as clinical treatment of pathological conditions, which includes ocular disorders, skin wound healing, and reconstructive surgery. The global amniotic membrane market was valued at $812 million in 2016, and is expected to reach $1,563 million by 2023, registering a CAGR of 9.7% during the forecast period.

The global amniotic membrane market is supplemented owing to its wide array of applications in areas such as ophthalmology, genitourinary tract, skin, brain, and head & neck as well as other surgical procedures. In addition, the rise in amniotic membrane based transplantations globally supplement the growth of the amniotic membrane market. However, the dearth of skilled professionals hinder the market growth. Moreover, the rise in awareness regarding the benefits of amniotic membrane in individuals as well as healthcare professionals will create more demand for amniotic membrane products, which is expected to boost the growth of the global amniotic membrane market.

Product Segment Review

The amniotic membrane market by product is bifurcated into cryopreserved amniotic membrane and lyophilized amniotic membrane. Lyophilized amniotic membrane can be stored at ambient temperatures for prolonged periods and helps prevent donor morbidity and enables management of the wound without using classical wound gauze. Thus, lyophilized amniotic membrane is expected to be a lucrative segment during the forecast period.

Get more information on this report : Request Sample Pages

Application Segment Review

The global amniotic membrane market by application is segmented into surgical wounds, ophthalmology, and others. Amniotic membrane is used in the field of ophthalmology for the treatment of number of conditions such as cicatricial pemphigoid and Stevens-Johnson syndrome, pterygium, persistent epithelial defects with ulceration, conjunctival surface reconstruction, and ocular surface reconstruction in patients with chemical and thermal burns. Thus, ophthalmology segment is expected to grow at a high CAGR during the forecast period.

Get more information on this report : Request Sample Pages

Amniotic Membrane Market by Region

Get more information on this report : Request Sample Pages

The global amniotic membrane market based on region is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the amniotic membrane market in 2016 and is expected to retain its dominance throughout the forecast period. This is attributed to the well-established healthcare infrastructure and the increase in adoption of amniotic membrane for various surgical procedures, such as skin, brain, and genitourinary tract.

The report provides a comprehensive analysis of the key players operating in the global amniotic membrane market such as FzioMed, Inc., Skye Biologics Inc., IOP Ophthalmics, Amniox Medical, Inc., Amnio Technology, LLC, Applied Biologics LLC, Alliqua BioMedical, Inc., Human Regenerative Technologies, LLC, Derma Sciences Inc., and MiMedx Group, Inc.
Other players operating in the value chain are AlloCure, Bellicum Pharmaceuticals, Biogen Idec, BIOTIME, Bone Therapeutics, Cell Medica, CESCA THERAPEUTICS, and Fibrocell Science.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis with the current trends and future estimations of the global amniotic membrane market to elucidate the imminent investment pockets.
  • Comprehensive analysis of the factors that drive and restrict the market growth is provided.
  • The quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of key segments of the industry is provided to understand the type of amniotic membrane used globally.
  • Key players and their strategies are analyzed to understand the competitive outlook of the market.

Amniotic Membrane Market Key Segments:

By Product

  • Cryopreserved Amniotic Membrane
  • Lyophilization Amniotic Membrane

By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers and Laboratory

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
  • Asia-Pacific
  • LAMEA

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top Winning Strategies, By Year, 2014-2017*
3.2.4. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.5. Top Winning Strategies, By Company, 2014-2017*

3.3. Porter’s Five Forces Analysis
3.4. Top Player Positioning
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Growth in geriatric population
3.5.1.2. Increasing technological advancements and rising amniotic membrane transplantations
3.5.1.3. Increased awareness to reduce healthcare costs

3.5.2. Restraints

3.5.2.1. Dearth of skilled professionals

3.5.3. Opportunities

3.5.3.1. Increasing awareness about the advantages of amniotic membrane transplant

CHAPTER 4: AMNIOTIC MEMBRANE MARKET BY PRODUCT

4.1. Overview
4.2. Market Size and Forecast
4.3. Cryopreserved Amniotic Membrane

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region

4.4. Lyophilization Amniotic Membrane

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region

CHAPTER 5: AMNIOTIC MEMBRANE MARKET BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Surgical Wounds

5.2.1. Market size and forecast by region

5.3. Ophthalmology

5.3.1. Market size and forecast by region

5.4. Others

5.4.1. Market size and forecast by region

CHAPTER 6: AMNIOTIC MEMBRANE MARKET BY END-USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast by region

6.3. Ambulatory Surgical Centers

6.3.1. Market size and forecast by region

6.4. Specialized Clinics

6.4.1. Market size and forecast by region

6.5. Research Centers & Laboratory

6.5.1. Market size and forecast by region

CHAPTER 7: AMNIOTIC MEMBRANE MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. North America Market size and forecast by country
7.2.2. North America Market size and forecast by Product
7.2.3. North America Market size and forecast by Application
7.2.4. North America Market size and forecast by End User

7.2.1.1. U.S. Market size and forecast by product
7.2.1.2. U.S. Market size and forecast by application
7.2.1.3. U.S. Market size and forecast by end user
7.2.1.4. Canada Market size and forecast by product
7.2.1.5. Canada Market size and forecast by application
7.2.1.6. Canada Market size and forecast by end user
7.2.1.7. Mexico Market size and forecast by product
7.2.1.8. Mexico Market size and forecast by application
7.2.1.9. Mexico Market size and forecast by end user

7.3. Europe

7.3.1. Europe Market size and forecast by product
7.3.1. Europe Market size and forecast by application
7.3.1. Europe Market size and forecast by end user

7.4. Asia-Pacific

7.4.1. Asia-Pacific market size and forecast, by product
7.4.2. Asia-Pacific market size and forecast, by application
7.4.3. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. LAMEA Market size and forecast by product
7.5.1. LAMEA Market size and forecast by application
7.5.1. LAMEA Market size and forecast by end user

CHAPTER 8: COMPANY PROFILES

8.1. Alliqua BioMedical Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. Amnio Technology, LLC

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments

8.3. Applied Biologics LLC

8.3.1. Company overview
8.3.2. Company snapshot

8.4. FzioMed Inc.

8.4.1. Company overview
8.4.2. Company snapshot

8.5. Human Regenerative Technologies, LLC

8.5.1. Company overview
8.5.2. Company snapshot

8.6. Integra Lifesciences Holdings Corporation (Derma Sciences Inc.)

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. Katena Products, Inc. (IOP Ophthalmics)

8.7.1. Company overview
8.7.2. Company snapshot

8.8. MiMedx Group Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance

8.9. Skye Biologics Inc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments

8.10. Tissue-Tech Inc. (Amniox Medical Inc.)

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL AMNIOTIC MEMBRANE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 02. GLOBAL CRYOPRESERVED AMNIOTIC MEMBRANE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 03. GLOBAL LYOPHILIZATION AMNIOTIC MEMBRANE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 04. GLOBAL AMNIOTIC MEMBRANE MAREKT, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 05. GLOBAL AMNIOTIC MEMBRANE MARKET FOR SURGICAL WOUNDS, BY REGION, 2016-2023 ($MILLION)
TABLE 06. GLOBAL AMNIOTIC MEMBRANE MARKET FOR OPHTHALMOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 07. GLOBAL AMNIOTIC MEMBRANE MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 08. GLOBAL AMNIOTIC MEMBRANE MAREKT, BY END USER, 2016-2023 ($MILLION)
TABLE 09. AMNIOTIC MEMBRANE MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. AMNIOTIC MEMBRANE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. AMNIOTIC MEMBRANE MARKET FOR SPECIALIZED CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. AMNIOTIC MEMBRANE MARKET FOR RESEARCH CENTERS & LABORATORY, BY REGION, 2016-2023 ($MILLION)
TABLE 13. AMNIOTIC MEMBRANE MARKET, BY REGION, 2012-2023 ($MILLION)
TABLE 14. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 18. U.S. AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 19. U.S. AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 20. U.S. AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 21. CANADA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 22. CANADA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 23. CANADA AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. MEXICO AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 25. MEXICO AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 26. MEXICO AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. EUROPE AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 28. EUROPE AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 29. EUROPE AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 33. LAMEA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 34. LAMEA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35. LAMEA AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. ALLIQUA: COMPANY SNAPSHOT
TABLE 37. AMNIO TECHNOLOGY: COMPANY SNAPSHOT
TABLE 38. APPLIED BIOLOGICS: COMPANY SNAPSHOT
TABLE 39. FZIOMED: COMPANY SNAPSHOT
TABLE 40. HRT: COMPANY SNAPSHOT
TABLE 41. INTEGRA: COMPANY SNAPSHOT
TABLE 42. INTEGRA: OPERATING SEGMENTS
TABLE 43. KATENA: COMPANY SNAPSHOT
TABLE 44. MIMEDX: COMPANY SNAPSHOT
TABLE 45. INTEGRA: OPERATING SEGMENTS
TABLE 46. SKYE: COMPANY SNAPSHOT
TABLE 47. TISSUETECH: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01. GLOBAL AMNIOTIC MEMBRANE MARKET, 2016-2023
FIGURE 02. AMNIOTIC MEMBRANE MARKET SEGMENTATION
FIGURE 03. TOP INVESTMENT POCKETS IN THE GLOBAL AMNIOTIC MEMBRANE MARKET
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 06. HIGH THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTION
FIGURE 08. MODERATE COMPETITIVE RIVALRY
FIGURE 09. GLOBAL AMNIOTIC MEMBRANE MARKET: TOP PLAYER POSITIONING
FIGURE 10. RESTRAINTS, DRIVERS & OPPORTUNITIES: GLOBAL AMNIOTIC MEMBRANE MARKET
FIGURE 11. AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY PRODUCT
FIGURE 12. AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY APPLICATION
FIGURE 13. AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY END USER
FIGURE 14. GLOBAL AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY REGION
FIGURE 15. ALLIQUA: NET SALES, 2014-2016 ($MILLION)
FIGURE 16. INTEGRA: NET SALES, 2014-2016 ($MILLION)
FIGURE 17. INTEGRA: REVENUE SHARE BY PRODUCT CATEGORIES, 2016 (%)
FIGURE 18. INTEGRA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 19. MIMEDX: NET SALES, 2014-2016 ($MILLION)
FIGURE 20. MIMEDX: REVENUE SHARE BY PRODUCT, 2016 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Have a question ?

Need to add more ?

Featured Readings

Get Fresh Content Delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Get Industry Data Alerts >